Jeremy Graff
Net worth: 35 248 $ as of 2026-08-30
Net worth: 35 248 $ as of 2026-08-30
Dr. Jeremy R.
Graff is a President & Chief Development Officer at Allarity Therapeutics, Inc. and a Chairman at IN8bio, Inc. He is on the Board of Directors at Wood Hudson Cancer Research Laboratory, Inc. Dr. Graff was previously employed as a Chief Scientific Officer by IMV, Inc., a Chief Development Officer & Senior VP-Research by HiberCell, Inc., a President & Chief Scientific Officer by Biothera Pharmaceuticals, Inc. (Delaware), and a President & Chief Scientific Officer by Biothera, Inc. He received his undergraduate degree from Thomas More University and a doctorate degree from the University of Kentucky.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-28 | 24,881 ( 0.16% ) | 35 082 $ | 2026-08-30 | |
| 2026-05-08 | 151 ( 0% ) | 166 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| IN8BIO, INC. | Chairman | 2026-02-27 |
| ALLARITY THERAPEUTICS, INC. | President | 2024-10-02 |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| IMV INC. | Chief Tech/Sci/R&D Officer | 2023-12-31 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Chief Tech/Sci/R&D Officer | 2021-02-28 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | President | 2020-05-31 |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | President | 2020-05-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Thomas More University
Thomas More University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Commercial Services |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions